Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Barclays Sticks to Their Sell Rating for Badger Meter (BMI)

Tipranks - Tipranks - Mon Apr 20, 8:26PM CDT

Barclays analyst William Grippin maintained a Sell rating on Badger Meter on April 17 and set a price target of $110.00. The company’s shares closed last Friday at $115.54.

Claim 30% Off TipRanks

According to TipRanks, Grippin is an analyst with an average return of -17.2% and a 26.92% success rate. Grippin covers the Industrials sector, focusing on stocks such as Republic Services, Waste Management, and Xylem.

Currently, the analyst consensus on Badger Meter is a Moderate Buy with an average price target of $175.88.

See the top stocks recommended by analysts >>

Based on Badger Meter’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $202.28 million and a net profit of $27.34 million. In comparison, last year the company earned a revenue of $222.21 million and had a net profit of $38.4 million

Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BMI in relation to earlier this year. Last month, Kimberly Stoll, the VP-Cust Serv & GM SmartCover of BMI sold 143.00 shares for a total of $20,663.50.

Read More on BMI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).